{"id":"https://openalex.org/W4310940908","doi":"https://doi.org/10.1002/oby.23612","title":"Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program","display_name":"Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program","alternate_titles":[],"publication_year":2022,"publication_date":"2022-12-07","ids":{"openalex":"https://openalex.org/W4310940908","doi":"https://doi.org/10.1002/oby.23612","pmid":"https://pubmed.ncbi.nlm.nih.gov/36478180","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10107501"},"language":"en","primary_location":{"id":"doi:10.1002/oby.23612","doi":"https://doi.org/10.1002/oby.23612","is_oa":true,"landing_page_url":"https://doi.org/10.1002/oby.23612","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23612","source":{"id":"https://openalex.org/S29918858","display_name":"Obesity","issn_l":"1930-7381","issn":["1930-7381","1930-739X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4310940908"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23612","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010753663","display_name":"Carel Wynand le Roux","orcid":"https://orcid.org/0000-0001-5521-5445","observed_orcids":["https://orcid.org/0000-0001-5521-5445"]},"institutions":[{"id":"https://openalex.org/I100930933","display_name":"University College Dublin","ror":"https://ror.org/05m7pjf47","country_code":"IE","type":"education","lineage":["https://openalex.org/I100930933"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carel W. le Roux","raw_affiliation_strings":["Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland"],"raw_orcid":"https://orcid.org/0000-0001-5521-5445","affiliations":[{"raw_affiliation_string":"Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland","institution_ids":["https://openalex.org/I100930933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100634784","display_name":"Shuyu Zhang","orcid":"https://orcid.org/0000-0003-1419-3635","observed_orcids":["https://orcid.org/0000-0003-1419-3635"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shuyu Zhang","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051043505","display_name":"Louis J. Aronne","orcid":"https://orcid.org/0000-0002-9890-9401","observed_orcids":["https://orcid.org/0000-0002-9890-9401"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Louis J. Aronne","raw_affiliation_strings":["Comprehensive Weight Control Center, Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York, New York, USA"],"raw_orcid":"https://orcid.org/0000-0002-9890-9401","affiliations":[{"raw_affiliation_string":"Comprehensive Weight Control Center, Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York, New York, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062192624","display_name":"Robert F. Kushner","orcid":"https://orcid.org/0000-0002-1380-3705","observed_orcids":["https://orcid.org/0000-0002-1380-3705"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert F. Kushner","raw_affiliation_strings":["Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"],"raw_orcid":"https://orcid.org/0000-0002-1380-3705","affiliations":[{"raw_affiliation_string":"Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021408335","display_name":"Ariana M. Chao","orcid":"https://orcid.org/0000-0001-5633-8973","observed_orcids":["https://orcid.org/0000-0001-5633-8973"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ariana M. Chao","raw_affiliation_strings":["University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania, USA"],"raw_orcid":"https://orcid.org/0000-0001-5633-8973","affiliations":[{"raw_affiliation_string":"University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091675017","display_name":"Sriram Machineni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sriram Machineni","raw_affiliation_strings":["Division of Endocrinology and Metabolism, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology and Metabolism, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080576431","display_name":"Julia P. Dunn","orcid":"https://orcid.org/0000-0001-9561-0183","observed_orcids":["https://orcid.org/0000-0001-9561-0183"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julia Dunn","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091091532","display_name":"Farai B. Chigutsa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Farai B. Chigutsa","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104159511","display_name":"Nadia N. Ahmad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nadia N. Ahmad","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110611896","display_name":"Mathijs C. M. Bunck","orcid":"https://orcid.org/0000-0002-2862-6705","observed_orcids":["https://orcid.org/0000-0002-2862-6705"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mathijs C. Bunck","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":"https://orcid.org/0000-0002-2862-6705","affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5110611896"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":{"value":4600,"currency":"USD","value_usd":4600},"fwci":13.9855,"has_fulltext":true,"cited_by_count":153,"citation_normalized_percentile":{"value":0.99794297,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"31","issue":"1","first_page":"96","last_page":"110"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":1.0},{"id":"https://openalex.org/keywords/weight-management","display_name":"weight management","score":0.703000009059906},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7879999876022339},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.8529999852180481},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.949999988079071},{"id":"https://openalex.org/keywords/lifestyle-intervention","display_name":"lifestyle intervention","score":0.7459999918937683},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6039999723434448},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5903657078742981},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4522278606891632},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15844818949699402}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000098860","descriptor_name":"Tirzepatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/oby.23612","doi":"https://doi.org/10.1002/oby.23612","is_oa":true,"landing_page_url":"https://doi.org/10.1002/oby.23612","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23612","source":{"id":"https://openalex.org/S29918858","display_name":"Obesity","issn_l":"1930-7381","issn":["1930-7381","1930-739X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10107501","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10107501","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10107501/pdf/OBY-31-96.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity (Silver Spring)","raw_type":"Text"},{"id":"pmid:36478180","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36478180","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity (Silver Spring, Md.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/oby.23612","doi":"https://doi.org/10.1002/oby.23612","is_oa":true,"landing_page_url":"https://doi.org/10.1002/oby.23612","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.23612","source":{"id":"https://openalex.org/S29918858","display_name":"Obesity","issn_l":"1930-7381","issn":["1930-7381","1930-739X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Obesity","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4310940908.pdf","grobid_xml":"https://content.openalex.org/works/W4310940908.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W807162506","https://openalex.org/W1572485915","https://openalex.org/W1957007052","https://openalex.org/W1991988767","https://openalex.org/W2043731116","https://openalex.org/W2063601306","https://openalex.org/W2068618758","https://openalex.org/W2069685969","https://openalex.org/W2084948079","https://openalex.org/W2096048424","https://openalex.org/W2109366467","https://openalex.org/W2139899193","https://openalex.org/W2178677810","https://openalex.org/W2394582105","https://openalex.org/W2609075277","https://openalex.org/W2615066072","https://openalex.org/W2734675357","https://openalex.org/W2764142960","https://openalex.org/W2784324162","https://openalex.org/W2895135221","https://openalex.org/W2895666357","https://openalex.org/W2896790246","https://openalex.org/W2902012675","https://openalex.org/W2915948028","https://openalex.org/W2980059388","https://openalex.org/W3004172664","https://openalex.org/W3028216699","https://openalex.org/W3097840647","https://openalex.org/W3131127077","https://openalex.org/W3177122952","https://openalex.org/W3177393241","https://openalex.org/W3183769527","https://openalex.org/W3191712049","https://openalex.org/W3205201678","https://openalex.org/W3210851898","https://openalex.org/W3210916260","https://openalex.org/W3214171772","https://openalex.org/W4205651374","https://openalex.org/W4205851616","https://openalex.org/W4210940103","https://openalex.org/W4248239717","https://openalex.org/W4251966062","https://openalex.org/W4281934192"],"related_works":["https://openalex.org/W4405025754","https://openalex.org/W4286457141","https://openalex.org/W4405617911","https://openalex.org/W4414075007","https://openalex.org/W4382050932","https://openalex.org/W4387653463","https://openalex.org/W7165876673","https://openalex.org/W7149592849","https://openalex.org/W4391902793","https://openalex.org/W4388673540"],"abstract_inverted_index":{"Objective":[0],"Obesity":[1],"is":[2,93],"a":[3,83,132,148],"growing":[4],"global":[5,60,164],"concern":[6],"compounded":[7],"by":[8],"limited":[9],"availability":[10],"of":[11,26,104,135,151,159,172],"effective":[12],"treatment":[13],"options.":[14],"The":[15,55,86,156],"SURMOUNT":[16,56,165],"development":[17],"program":[18,57,166],"aims":[19],"to":[20,31,76,102,137,144,153],"evaluate":[21],"the":[22,94,108,120,163,169],"efficacy":[23],"and":[24,70,117,146,178],"safety":[25],"tirzepatide":[27,79,161],"as":[28],"an":[29],"adjunct":[30],"lifestyle":[32],"intervention":[33],"compared":[34],"with":[35,43,48],"placebo":[36,81],"on":[37],"chronic":[38,184],"weight":[39,99,185],"management":[40],"in":[41,82,90,97,125,162,183],"adults":[42],"BMI":[44,150],"\u2265":[45],"27":[46],"kg/m2":[47],"or":[49],"without":[50],"type":[51],"2":[52],"diabetes.":[53],"Methods":[54],"includes":[58],"four":[59],"phase":[61],"3":[62],"trials":[63,92,122],"NCT04184622":[64],"(SURMOUNT\u20101),":[65],"NCT04657003":[66],"(SURMOUNT\u20102),":[67],"NCT04657016":[68],"(SURMOUNT\u20103),":[69],"NCT04660643":[71],"(SURMOUNT\u20104).":[72],"Participants":[73],"are":[74,123,140],"randomized":[75],"once\u2010weekly":[77,160],"subcutaneous":[78],"versus":[80],"double\u2010blind":[84],"manner.":[85],"primary":[87,109],"end":[88,103,110],"point":[89,111],"all":[91],"percentage":[95],"change":[96],"body":[98],"from":[100],"randomization":[101],"treatment.":[105],"Results":[106,127],"for":[107,112,119],"SURMOUNT\u20101":[113],"were":[114],"published":[115],"recently":[116],"results":[118],"other":[121],"expected":[124],"2023.":[126],"Across":[128],"trials,":[129],"participants":[130],"have":[131,147],"mean":[133,149],"age":[134],"44.9":[136],"54.2":[138],"years,":[139],"mostly":[141],"female":[142],"(50.7%":[143],"69.7%),":[145],"36.1":[152],"38.9.":[154],"Conclusions":[155],"extensive":[157],"assessment":[158],"will":[167],"detail":[168],"clinical":[170],"effects":[171],"this":[173],"first\u2010in\u2010class":[174],"glucose\u2010dependent":[175],"insulinotropic":[176],"polypeptide":[177],"glucagon\u2010like":[179],"peptide\u20101":[180],"receptor":[181],"agonist":[182],"management.":[186]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4310940908","counts_by_year":[{"year":2026,"cited_by_count":26},{"year":2025,"cited_by_count":66},{"year":2024,"cited_by_count":40},{"year":2023,"cited_by_count":21}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-12-21T00:00:00"}
